Remedy for relapsed/refractory condition need to be made the decision determined by prior therapy as well as the reason why the initial therapy was not correct (e.g., refractoriness vs. intolerance). Ibrutinib is The present gold normal therapy for patients with relapsed/refractory ailment, based on the final results of several phase I-III trials, … Read More